P

Palisade Bio
D

PALI

1.94500
USD
-0.05
(-2.49%)
قبل الجلسة·2.05000USD+0.10500(+5.40%)
حجم التداول
47,230
الربح لكل سهم
-0
العائد الربحي
-
P/E
16
حجم السوق
338,001,458
المقالات
المزيد

العنوان: Palisade Bio

القطاع: Healthcare
الصناعة: Biotechnology
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.